Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elaine Gray

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Handbook of Experimental Pharmacology|May 9, 2012
Standardisation of unfractionated and low-molecular-weight heparinElaine Gray
Handbook of Experimental Pharmacology|March 31, 2026
Haemostasis and the Need for Antithrombotics: An IntroductionJohn Hogwood, Elaine Gray
Handbook of Experimental Pharmacology|December 30, 2025
Heparin: Over 100 Years of AnticoagulationJohn Hogwood, Elaine Gray
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|January 12, 2017
Research notesSylvia Cavanagh, Elaine Gray
Vox Sanguinis|December 5, 2020
Enabling accurate measurement of activated factor XI (FXIa) in therapeutic immunoglobulin productsHelen V Wilmot, Elaine Gray
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 28, 2018
Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagentHelen V Wilmot, Elaine Gray
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2020
Activity measurements of dalcinonacog alfaStella C Williams, Elaine Gray
Professional Nurse (London, England)|March 29, 2002
Qualitative research on admission procedures in elderly careElaine Gray, Sylvia Cavanagh, Harriet Mowat
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Handbook of Experimental Pharmacology|May 9, 2012
Standardisation of unfractionated and low-molecular-weight heparinElaine Gray
Handbook of Experimental Pharmacology|March 31, 2026
Haemostasis and the Need for Antithrombotics: An IntroductionJohn Hogwood, Elaine Gray
Handbook of Experimental Pharmacology|December 30, 2025
Heparin: Over 100 Years of AnticoagulationJohn Hogwood, Elaine Gray
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|January 12, 2017
Research notesSylvia Cavanagh, Elaine Gray
Vox Sanguinis|December 5, 2020
Enabling accurate measurement of activated factor XI (FXIa) in therapeutic immunoglobulin productsHelen V Wilmot, Elaine Gray
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 28, 2018
Potency estimates for recombinant factor IX in the one-stage clotting assay are influenced by more than just the choice of activated partial thromboplastin time reagentHelen V Wilmot, Elaine Gray
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2020
Activity measurements of dalcinonacog alfaStella C Williams, Elaine Gray
Professional Nurse (London, England)|March 29, 2002
Qualitative research on admission procedures in elderly careElaine Gray, Sylvia Cavanagh, Harriet Mowat
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Pageof 6